These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33407056)

  • 1. Acute otitis media and pneumococcal vaccination - an observational cross-sectional study of otitis media among vaccinated and unvaccinated children in Greenland.
    Jespersen SI; Demant MN; Pedersen ML; Homøe P
    Int J Circumpolar Health; 2021 Dec; 80(1):1858615. PubMed ID: 33407056
    [No Abstract]   [Full Text] [Related]  

  • 2. Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial.
    Leach AJ; Mulholland EK; Santosham M; Torzillo PJ; McIntyre P; Smith-Vaughan H; Wilson N; Arrowsmith B; Beissbarth J; Chatfield MD; Oguoma VM; Morris PS
    BMC Pediatr; 2021 Mar; 21(1):117. PubMed ID: 33685411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine.
    Casey JR; Adlowitz DG; Pichichero ME
    Pediatr Infect Dis J; 2010 Apr; 29(4):304-9. PubMed ID: 19935445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of 13-valent pneumococcal conjugate vaccination for protection against acute otitis media caused by Streptococcus pneumoniae in healthy young children: a prospective observational study.
    Pichichero M; Kaur R; Scott DA; Gruber WC; Trammel J; Almudevar A; Center KJ
    Lancet Child Adolesc Health; 2018 Aug; 2(8):561-568. PubMed ID: 30119715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines.
    Leach AJ; Wigger C; Beissbarth J; Woltring D; Andrews R; Chatfield MD; Smith-Vaughan H; Morris PS
    Int J Pediatr Otorhinolaryngol; 2016 Jul; 86():224-32. PubMed ID: 27260611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of acute otitis media from 2003 to 2019 in children ≤ 17 years in England.
    Mohanty S; Podmore B; Cuñado Moral A; Weiss T; Matthews I; Sarpong E; Méndez I; Qizilbash N
    BMC Public Health; 2023 Jan; 23(1):201. PubMed ID: 36717794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Widespread Introduction of Pneumococcal Conjugate Vaccines on Pneumococcal and Nonpneumococcal Otitis Media.
    Ben-Shimol S; Givon-Lavi N; Leibovitz E; Raiz S; Greenberg D; Dagan R
    Clin Infect Dis; 2016 Sep; 63(5):611-8. PubMed ID: 27225239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcus pneumoniae as cause of acute otitis media (AOM) in Slovak children in the pneumococcal conjugate vaccine era (2008-2019).
    Macaj M; Perdochova L; Jakubikova J
    Vaccine; 2023 Jan; 41(2):452-459. PubMed ID: 36470684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial etiology of acute otitis media in the era prior to universal pneumococcal vaccination in Taiwanese children.
    Kung YH; Chiu NC; Lee KS; Chang L; Huang DT; Huang FY; Hsieh YC; Huang LM; Chi H
    J Microbiol Immunol Infect; 2014 Jun; 47(3):239-44. PubMed ID: 24080520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia.
    Lagoubi Y; Sfar MT; Gomez JA
    Hum Vaccin Immunother; 2022 Nov; 18(5):2079305. PubMed ID: 35703731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
    de Sévaux JL; Venekamp RP; Lutje V; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD001480. PubMed ID: 33231293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules.
    Leach AJ; Wigger C; Andrews R; Chatfield M; Smith-Vaughan H; Morris PS
    BMC Pediatr; 2014 Aug; 14():200. PubMed ID: 25109288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pneumococcal conjugate vaccines on healthcare utilization and direct costs for otitis media in children ≤2 years of age in two Swedish regions.
    Edmondson-Jones M; Dibbern T; Hultberg M; Anell B; Medin E; Feng Y; Talarico C
    Hum Vaccin Immunother; 2022 Dec; 18(1):1942712. PubMed ID: 34319865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of acute otitis media, recurrent otitis media and tympanostomy tube insertion in children after its implementation into the national immunization program in Turkey.
    Soysal A; Gönüllü E; Yıldız I; Aydemir G; Tunç T; Fırat Y; Erdamar B; Karaböcüoğlu M
    Hum Vaccin Immunother; 2020; 16(2):445-451. PubMed ID: 31424317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland.
    Vesikari T; Forsten A; Seppä I; Kaijalainen T; Puumalainen T; Soininen A; Traskine M; Lommel P; Schoonbroodt S; Hezareh M; Moreira M; Borys D; Schuerman L
    J Pediatric Infect Dis Soc; 2016 Sep; 5(3):237-248. PubMed ID: 27125273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal conjugate vaccines for preventing acute otitis media in children.
    Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2019 May; 5(5):CD001480. PubMed ID: 31135969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal conjugate vaccines for preventing otitis media.
    Fortanier AC; Venekamp RP; Boonacker CW; Hak E; Schilder AG; Sanders EA; Damoiseaux RA
    Cochrane Database Syst Rev; 2014 Apr; (4):CD001480. PubMed ID: 24696098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal vaccines for preventing otitis media.
    Straetemans M; Sanders EA; Veenhoven RH; Schilder AG; Damoiseaux RA; Zielhuis GA
    Cochrane Database Syst Rev; 2004; (1):CD001480. PubMed ID: 14973970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pneumococcal conjugated vaccines on occurrence of recurrent acute otitis media among infants diagnosed with acute otitis media at an age younger than 2 months.
    Ziv O; Adelson D; Sadeh R; Kordeluk S; El-Saied S; Leibovitz E; Kraus M; Kaplan D
    Eur J Pediatr; 2023 Jun; 182(6):2873-2879. PubMed ID: 37052673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in All-Cause Acute Otitis Media in Children <3 Years of Age in Primary Care Following Vaccination With 10-Valent Pneumococcal Haemophilus influenzae Protein-D Conjugate Vaccine: A Whole-Population Study.
    Sigurdsson S; Eythorsson E; Hrafnkelsson B; Erlendsdóttir H; Kristinsson KG; Haraldsson Á
    Clin Infect Dis; 2018 Sep; 67(8):1213-1219. PubMed ID: 29617959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.